MAY 22 – 24, 2017: Pharmaceutical Traceability Forum
Welcome back to the premier industry event on global serialization regulations & guidelines!
With the guideline in the serialization process underway and approaching, it appears as though there are two different categories that pharmaceutical companies currently fall into: those who have and those who have not. While the industry is well aware of the regulatory deadlines in both the United States and across the globe, there are still matters to be clarified. But what exactly is not clear? One of the biggest concerns is the deployment process and how this will affect current and future products. The Pharmaceutical Traceability Forum will conduct various conversations focusing on the complexities associated with integrating a serialization process at your organization, as well as the possible solution for the impeding issues. Participate in the conversation!
With the guideline in the serialization process underway and approaching, it appears as though there are two different categories that pharmaceutical companies currently fall into: those who have and those who have not. While the industry is well aware of the regulatory deadlines in both the United States and across the globe, there are still matters to be clarified. But what exactly is not clear? One of the biggest concerns is the deployment process and how this will affect current and future products. The Pharmaceutical Traceability Forum will conduct various conversations focusing on the complexities associated with integrating a serialization process at your organization, as well as the possible solution for the impeding issues. Participate in the conversation!
